147 related articles for article (PubMed ID: 8837356)
1. A new low-incidence antigen in the Kell blood group system: VLAN (KEL25).
Jongerius JM; Daniels GL; Overbeeke MA; Petty AC; Reid M; Oyen R; Rijksen H; van Leeuwen EF
Vox Sang; 1996; 71(1):43-7. PubMed ID: 8837356
[TBL] [Abstract][Full Text] [Related]
2. Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system.
Lee S; Reid ME; Redman CM
Vox Sang; 2001 Nov; 81(4):259-63. PubMed ID: 11904003
[TBL] [Abstract][Full Text] [Related]
3. Demonstration by the monoclonal antibody-specific immobilization of erythrocyte antigens assay that a new red cell antigen belongs to the Kell blood group system.
Daniels GL; Petty AC; Reid M; Moulds M; Devenish A; Halil O
Transfusion; 1994 Sep; 34(9):818-20. PubMed ID: 8091473
[TBL] [Abstract][Full Text] [Related]
4. K23. A low-incidence antigen in the Kell blood group system identified by biochemical characterization.
Marsh WL; Redman CM; Kessler LA; DiNapoli J; Scarborough AL; Philipps AG; Mody KM
Transfusion; 1987; 27(1):36-40. PubMed ID: 3810821
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide.
Advani H; Zamor J; Judd WJ; Johnson CL; Marsh WL
Br J Haematol; 1982 May; 51(1):107-15. PubMed ID: 7073987
[TBL] [Abstract][Full Text] [Related]
6. The Kmod blood group phenotype in a healthy individual.
Winkler MM; Beattie KM; Cisco SL; Sigmund KE; Johnson CL; Rabin BI; Marsh WL
Transfusion; 1989 Sep; 29(7):642-5. PubMed ID: 2773032
[TBL] [Abstract][Full Text] [Related]
7. K12 is located on the Kell blood group protein in proximity to K/k and Jsa/Jsb.
Reid ME; Oyen R; Redman CM; Gillespie G; Jones J; Eckrich R
Vox Sang; 1995; 68(1):40-5. PubMed ID: 7725670
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.
Velliquette RW; Hue-Roye K; Lomas-Francis C; Gillen B; Schierts J; Gentzkow K; Peyrard T; von Zabern I; Flegel WA; Rodberg K; Debnath AK; Lee S; Reid ME
Transfusion; 2013 Nov; 53(11 Suppl 2):2872-81. PubMed ID: 23560718
[TBL] [Abstract][Full Text] [Related]
9. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells.
Daniels GL; Weinauer F; Stone C; Ho M; Green CA; Jahn-Jochem H; Offner R; Monaco AP
Blood; 1996 Nov; 88(10):4045-50. PubMed ID: 8916972
[TBL] [Abstract][Full Text] [Related]
10. A rare example of weakened expression of the Kell (K1) antigen.
Kline WE; Sullivan CM; Bowman RJ
Vox Sang; 1984; 47(2):170-3. PubMed ID: 6464416
[TBL] [Abstract][Full Text] [Related]
11. Expansion of the Kell blood group system: two new high-prevalence antigens and two novel K0 (Kellnull ) phenotypes.
Lomas-Francis C; Vege S; Velliquette RW; Fuchisawa A; Uchikawa M; Tani Y; Moro H; Debnath AK; Westhoff CM
Transfusion; 2013 Nov; 53(11 Suppl 2):2887-91. PubMed ID: 23968329
[TBL] [Abstract][Full Text] [Related]
12. A novel common Kell antigen, TOU, and its spatial relationship to other Kell antigens.
Jones J; Reid ME; Oyen R; Harris T; Moscarelli S; Co S; Leger R; Beal C; Cardillo K
Vox Sang; 1995; 69(1):53-60. PubMed ID: 7483493
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM.
Lee S; Debnath AK; Wu X; Scofield T; George T; Kakaiya R; Yogore MG; Sausais L; Yacob M; Lomas-Francis C; Reid ME
Transfusion; 2006 Aug; 46(8):1323-7. PubMed ID: 16934067
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens.
Yu LC; Twu YC; Chang CY; Lin M
J Biol Chem; 2001 Mar; 276(13):10247-52. PubMed ID: 11134029
[TBL] [Abstract][Full Text] [Related]
15. K22, a 'new' para-Kell antigen of high frequency.
Bar Shany S; Ben Porath D; Levene C; Sela R; Daniels GL
Vox Sang; 1982 Feb; 42(2):87-90. PubMed ID: 7064432
[TBL] [Abstract][Full Text] [Related]
16. Kell blood group antigens are part of a 93,000-dalton red cell membrane protein.
Redman CM; Avellino G; Pfeffer SR; Mukherjee TK; Nichols M; Rubinstein P; Marsh WL
J Biol Chem; 1986 Jul; 261(20):9521-5. PubMed ID: 2424912
[TBL] [Abstract][Full Text] [Related]
17. [Rare blood donors with irregular antibodies].
Milanović MK; Bujandrić N; Knezević NM
Med Pregl; 2013; 66(7-8):331-4. PubMed ID: 24069817
[TBL] [Abstract][Full Text] [Related]
18. Unusual suppression of Kell system antigens in a healthy blood donor.
Norman PC; Daniels GL
Transfusion; 1988; 28(5):460-2. PubMed ID: 3420674
[TBL] [Abstract][Full Text] [Related]
19. Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells.
Branch DR; Sy Siok Hian AL; Petz LD
Br J Haematol; 1985 Mar; 59(3):505-12. PubMed ID: 2578808
[TBL] [Abstract][Full Text] [Related]
20. Use of a modified procedure for treating small amounts of red blood cells with 2-aminoethylisothiouronium bromide.
Ellisor SS; O'Day T; Reid ME; Arndt L; Sugasawara E
Am J Clin Pathol; 1984 Oct; 82(4):439-41. PubMed ID: 6206714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
